The FDA approved a high-concentration, citrate-free version of Boehringer Ingelheim’s Cyltezo (adalimumab-adbm), making it ...
Medscape Medical News, October 06, 2023 Alert FDA OKs Ninth Humira Biosimilar, With Interchangeability The drug, adalimumab-afzb (Abrilada), is the second adalimumab biosimilar approved with ...
Comorbidities, CV Risk Factors Common in Early PsA Data illustrated increased odds of metabolic burden in adults newly diagnosed with psoriatic arthritis. Medscape Medical News, September 11, 2023 ...